Foster Dykema Cabot & Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Foster Dykema Cabot & Partners's LLY Position: Q3 2026 in Review
Foster Dykema Cabot & Partners reduced its Eli Lilly (LLY) stake by 0.93% in Q3 2026, selling an estimated $307K and leaving 27,765 shares worth $32.1M. The position accounts for 1.69% of the portfolio, ranked #16.
Foster Dykema Cabot & Partners first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $39.6M in Q2 2024. 4,580 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Foster Dykema Cabot & Partners held 27,765 shares of Eli Lilly worth $32.1M as of Q3 2026.
- Foster Dykema Cabot & Partners sold 260 Eli Lilly shares in Q3 2026, an estimated $307K.
- Eli Lilly made up 1.69% of Foster Dykema Cabot & Partners's portfolio in Q3 2026, its #16 holding.
- Foster Dykema Cabot & Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
- Foster Dykema Cabot & Partners's Eli Lilly position peaked at $39.6M in Q2 2024.
- 4,580 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Foster Dykema Cabot & Partners's 13F filing for Q3 2026, filed 30 Oct 2026.